Oncoclinicas do Brasil (ONCO3) — Cash Flow Quality Index
Oncoclinicas do Brasil (ONCO3) has a Cash Flow Quality Index of 35.94x as of September 2024. Operating cash flow of R$112.14 Million exceeds net income of R$3.12 Million, indicating high earnings quality where cash backs reported profits. Explore Oncoclinicas do Brasil operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oncoclinicas do Brasil Cash Flow Quality Index (2013–2023)
Historical Cash Flow Quality Index for Oncoclinicas do Brasil across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Oncoclinicas do Brasil investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Oncoclinicas do Brasil (2013–2023)
Year-by-year earnings quality comparison for Oncoclinicas do Brasil. For live market cap and the full company financial profile, see ONCO3 market cap.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.23x | R$-51.56 Million | R$223.62 Million | ▲ +90.3% |
| 2022 | -2.39x | R$-271.64 Million | R$113.77 Million | ▼ -147.0% |
| 2019 | 5.08x | R$97.08 Million | R$19.10 Million | ▲ +112.7% |
| 2018 | 2.39x | R$38.86 Million | R$16.26 Million | ▼ -94.4% |
| 2017 | 43.01x | R$135.26 Million | R$3.15 Million | ▲ +11910.7% |
| 2013 | 0.36x | R$7.34 Million | R$20.50 Million | — |